Keith A. Bostian Named President of Kemin Pharma
9/18/2008 2:46:05 PM
HERENTALS, Belgium--(BUSINESS WIRE)--Kemin Industries today named Keith A. Bostian, PhD, President of Kemin Pharma. Dr. Bostian joins Kemin from Mpex Pharmaceuticals, Inc. where he served as Chief Scientific Officer and innovator of the company’s R&D platform. Dr. Bostian will add significant biopharmaceutical industry, financial and operational experience to Kemin as the Company continues to progress its clinical and preclinical programs.
comments powered by